{
    "Trade/Device Name(s)": [
        "ACURA PLUS Multi Blood Glucose Monitoring System",
        "ACURA PLUS Multi Blood Glucose Meter",
        "ACURA PLUS Multi Blood Glucose Test Strips",
        "ACURA PLUS Control Solutions"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K131419",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103278"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "August 9, 2013",
    "Summary Letter Received Date": "July 11, 2013",
    "Submission Date": "July 10, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACURA PLUS Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method",
        "Glucose oxidase (Aspergillus sp.)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solutions"
    ],
    "Document Summary": "FDA 510(k) summary for ACURA PLUS Multi Blood Glucose Monitoring System for quantitative glucose measurement in whole blood using electrochemical biosensor.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites, for multiple-patient use in professional healthcare settings to aid diabetes control; not for neonatal, diagnostic, or screening use.",
    "fda_folder": "Clinical Chemistry"
}